Kareem A. Ibrahim

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Novel anti-virulence strategy against Helicobacter pylori using Lactiplantibacillus plantarum cell-free supernatants.

Novel anti-virulence strategy against Helicobacter pylori using Lactiplantibacillus plantarum cell-free supernatants.

Journal: Frontiers in microbiology

Published: May 14, 2026

Oral-gut microbiome dysbiosis in obese smokers reveals compartment-specific shifts.

Oral-gut microbiome dysbiosis in obese smokers reveals compartment-specific shifts.

Journal: AMB Express

Published: January 07, 2026

A Potential Probiotic Lactiplantibacillus Plantarum Isolate from Egyptian Cottage Cheese Alleviates Metabolic Syndrome Manifestations: In Vitro and In Vivo Characterization.

A Potential Probiotic Lactiplantibacillus Plantarum Isolate from Egyptian Cottage Cheese Alleviates Metabolic Syndrome Manifestations: In Vitro and In Vivo Characterization.

Journal: Probiotics and antimicrobial proteins

Published: September 08, 2025

Repurposing rupatadine as topical treatment against methicillin-resistant Staphylococcus aureus.

Repurposing rupatadine as topical treatment against methicillin-resistant Staphylococcus aureus.

Journal: AMB Express

Published: July 03, 2025

Computational guided identification of novel anti-mycobacterial agent proved by in-vitro and in-vivo validation.

Computational guided identification of novel anti-mycobacterial agent proved by in-vitro and in-vivo validation.

Journal: BMC microbiology

Published: April 30, 2025

Alanine racemase a promising Helicobacter pylori drug target inhibited by propanoic acid.

Alanine racemase a promising Helicobacter pylori drug target inhibited by propanoic acid.

Journal: Microbes and infection

Published: September 12, 2022

Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection.

Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection.

Journal: Frontiers in microbiology

Published: August 15, 2022

Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing.

Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing.

Journal: Pathogens (Basel, Switzerland)

Published: July 20, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026